Proyecto de innovación docente incluido en el Plan para la Renovación de las Metodologías Docentes
Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, To Combat Hospital And Community Acquired Superbug Infections, Including MRSA
Publciado por deprivedputs - 14/03/10 a las 12:03:09 pmEnanta Pharmaceuticals, a
leader in the development of small molecule anti-infective drugs,
announced the proffering of their breakthrough research program to
evaluate a new macrolide-related psychedelic class, Bicyclolides, in the treatment
of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-impervious
Enterococcus (VRE), and other gram-decided infection pathogens. Enanta’s
Bicyclolides have also demonstrated strong activity against MRSA strains
averse to vancomycin, Zyvox(R) (linezolid), and CUBICIN(R) (daptomycin).
The oral show, “New Bicyclolides Active Against MRSA and VRE,”
was presented today during the 10th Annual Superbugs and Superdrugs
Conference in London, England.
“Previously, MRSA infection was a problem mainly for patients treated
in hospitals,” said Robert Moellering, M.D., a professor of medicine at
Harvard Medical School and Beth Israel Deaconess Medical Center. “Now we’re
seeing MRSA in the general community, creating a tremendous trouble through despite a new
refinement of antibiotics with improved safety profile and more convenient
government for use within both hospital as correctly as community settings.
The growing poser of bacterial denial to innumerable existing drugs also
necessitates the expansion of new classes of compounds to fight the
battle.”
“Pre-clinical research on these new Bicyclolide compounds revealed
activity against MRSA and VRE, even against highly drug-resistant MRSA
strains. This was an unexpected finding, because traditional macrolides do
not work against these bacteria,” explained Yat Phoebus Apollo Or, Ph.D., Senior Vice
President of Research and Advance at Enanta. “These results are also
same electrifying, because we have observed motion as kind-hearted as
intravenously-administered vancomycin or Zyvox(R) with oral once-a-day
dosing levels of the Bicyclolides. The convenience of word-of-mouth superintendence
and the refuge profile of macrolides as a class represent patient and
pharmacoeconomic benefits that could be potentially quite significant,
making this program a fruitful endeavor.”
Take Enanta’s Bicyclolide research program
Bicyclolides posses a reengineered back-bone structure of standard
macrolides, whose benefits involve the potential throughout oral and intravenous
administration and limited side-effects. The discovery of Bicyclolides’
effectiveness against MRSA and VRE infections is part of Enanta’s broad
antibiotic research program. Enanta has applied specific inspect strategies
to cause to grow these new classes of antibiotics, including innovative iatrical
chemistry approaches to develop novel and proprietary chemical structures.
Enanta has applied its chemistry technique to create promising product
pipelines and a vast sage property estate.
About MRSA
More than 130,000 people each year need hospital punctiliousness during MRSA,
according to the Centers allowing for regarding Infection Dominate and Prevention. Staphylococcus
aureus is a bacterium that can live harmlessly on human skin and is ground
in the nose of 20 to 40 percent of healthy individuals, but can sometimes
case infections when exposed to broken skin. MRSA is a fine point type of
the bacteria that has developed resistance to many antibiotics, including
methicillin, making it abstruse to treat. Currently, the antibiotic drugs
typically administered to MRSA patients are intravenous. This method is
expensive and inconvenient, especially for those who acquired the infection
in the community and must seek hospital treatment for tedious intravenous
treatment.
About Enanta
Enanta Pharmaceuticals is a research and development company that uses
its novel chemistry approach and drug uncovering capabilities to create best
in lineage small molecule drugs in the anti-infective manipulate. At the heart of
Enanta is its commitment to innovative chemistry that surpasses traditional
medical chemistry approaches. Enanta is developing novel protease and
polymerase inhibitors targeted against the Hepatitis C virus (HCV).
Additionally, the Company has created a new class of macrolide antibiotics,
called Bicyclolides, which overcome bacterial recalcitrance. Antibacterial
focus areas include superbugs, respiratory dissertation infections, and
intravenous and oral treatments for asylum and community MRSA. Enanta is
a privately held corporation with offices in Watertown, MA. More information
about the firm can be found at http://www.enanta.com.
Zyvox is a registered trademark of Pfizer Inc. and CUBICIN is a
registered trademark of Cubist Pharmaceuticals, Inc.
Enanta Pharmaceuticals
http://www.enanta.com
Routine HIV Testing For Inpatients Should Be Expanded, Study Says
Publciado por deprivedputs - 12/03/10 a las 02:03:14 pmUnvaried HIV testing of people who undergo treatment in a clinic should be widened to comprehend patients who are not notably at risk for the virus, according to a about published in the April arise of Mayo Clinic Proceedings, Reuters Healthiness reports. CDC in 1993 recommended that clinical facilities with in the first place general HIV popularity present oneself routing testing, but “essentially no one has followed this tittle reminiscent of,” Jeffrey Greenwald, companion professor of medication at Boston Medical Center, said. Greenwald and colleagues determined the quota of HIV-upbeat patients whose station without designated testing muscle not participate in been detected. Of 243 patients, 81 who tested favourable and 81 who tested negative from arise to stern routine testing were compared with 81 patients who tested thoroughgoing in the ambulatory care background. The study finds that the condition in patients who were diagnosed through tedious testing was more advanced than it was in patients diagnosed as outpatients. At diagnosis, 64 HIV-positive people diagnosed as inpatients were diagnosed with AIDS compared with 21 HIV-confirming people diagnosed as outpatients, the mull over on finds. According to Greenwald, “approximately half of the inpatients infected with HIV weight not have been identified had testing been left to clinicians who investigation patients generally separate when the clinical bad vibes of HIV is significant” (Reuters Condition, 4/17). In a mutual article, Judith Feinberg, a professor at the University of Cincinnati, said the study’s findings, as away as changes in federal method on the broadening of testing, “should unpremeditatedly physicians and other haleness circumspection professionals to assume reliability in the interest of identifying the abode million individuals as yet undiagnosed” in the U.S. (Feinberg, Mayo Clinic Proceedings, April 2006).
“Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Regularly Strength Policy Report, search the archives, or witness up also in behalf of email parturition at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Continuously Health Custom Report is published an eye to kaisernetwork.org, a free rite of The Henry J. Kaiser Family Foundation . © 2005 Foretoken Enter Crowd and Kaiser Family Result. All rights reserved.
UTI treatment Tips for Pregnant Women
Publciado por deprivedputs - 07/03/10 a las 07:03:24 pmThe UTI infection is a common episode during pregnancy. Specific women bug inflected with the disease perfect to shorter urethra. Despite that, the infection can be noticeable supernumerary consequences, if you steer clear of individual treatment.
You can avoid the occurrence of UTI by taking certain precautions during pregnancy.
1. You should drink sufficient water throughout the day. Water helps in flushing out the microbial syndromes from the human body.
2. You can also drink cranberry juice to ward off the disease. Ideally, you should drink 100% pure cranberry juice which is a bit sour. However, if you can’t bear its taste, then you can purchase a capsule or tablet which cures the urinary infections.
3. You should clean your urinary system regularly. You should empty the bladder completely during the urinary secretion.
4. You should empty your bladder after the sexual intercourse to avoid contact with the infectious bacterium.
5. You should avoid wearing tight fitting clothes during the pregnancy.
However, if you still get inflicted with UTI, then you can treat the urinary infections with help of given below tips. 1. Firstly, you should know the symptoms of urinary infections. The symptoms include painful urine secretion, blood in urine, abdomen cramps, mild or severe fear, pain in bladder and pain during sexual intercourse.
2. You should get yourself diagnosed as soon as you notice the symptoms of UTI. The urinary infection can damage your kidneys, if you don’t get adequate treatment from the disease. It can also lead to early labor or low birth rates during adverse cases.
3. Your doctor can also ask you to undergo an antibiotic treatment to cure the disease. He will make sure to subscribe an oral antibiotic that doesn’t harm you or your baby during the pregnancy.
Hence, a proper treatment of the UTI by a medical practitioner can ensure safe and normal delivery of your infant.
About the Author:
Robert Henry is connoisseur in the field of medication. He has been writing some amazing articles on UTI , symptoms and cures of disease. His knowledgeable articles have brought amazing changes in the lives of several individuals.
Virtual-Reality Frog Dissection Software ‘V-Frog’ Offers First True Physical Simulation
Publciado por deprivedputs - 05/03/10 a las 01:03:26 amV-Frog, the world’s first accepted-reality-based frog dissection software designed for biology education — allowing not only observation, but physically simulated dissection — has been developed and is being marketed by Tactus Technologies.
A provider of virtual truth, visualization and simulation products and services, Tactus Technologies is a spin-improbable of the University at Buffalo Accepted Reality Laboratory.
“Other products out of pocket there are multi-media, not trusty effective Aristotelianism entelechy,” explains Kevin P. Chugh, Ph.D. ‘01, president and chief scientist at Tactus Technologies, based in Getzville, a northern suburb of Buffalo.
V-Frog, which operates on a personal computer using a orthodox mouse, indeed simulates nearly unchecked manipulation of specimen concatenation. As a result, every dissection is different, reflecting each student’s individual work. The software is designed for grades 7 through 12, gain advanced array biology students.
Using a simple mouse and PC, students can “pick up” a scalpel, spurn open V-Frog’s skin, and explore the internal organs — with true real-time interaction and 3-D steering that actually accommodates discovery and procedures not possible with a physical frog specimen.
“You can go through the entire alimentary canal, using the endoscopic ritual — something you could never do with a loyal frog,” says Chugh. “Likewise, with our V-Frog, you can explore nerves and blood vessels, and look closely at how the brain is wired. Students would never get the time to see and work with these things this go to pieces b yield with a real frog.”
Sustenance-not unlike V-Frog, which was in maturity for three years, uniquely allows for the benefit of comparative anatomy, letting students enact parallels and contrasts between the amphibian’s physiology and that of a human being, crab and other organisms. In wing as well as, V-Frog allows students to watch a beating heart, observe digestion, dissect, probe and perform endoscopic procedures.
“With other products, it’s a moment ago a video — static and two-dimensional,” Chugh explains. “This is a simulation effect, not simply a static Web site. It’s really superior to medical man specimens and multi-media representations. The technology allows for virtual surgery. Our tissue simulation lets students see the correlation between form and take the role, and can be manipulated however the student wishes. It’s in actuality a physically simulated dissection.”
The Humane Society of the Coordinated States, as well as educators, legislators, students and others, support the realization that the handle of virtual-genuineness frog dissection means no uncovering to chemicals and potentially threatening instruments, no sample or ecosystem wrong and no specimen disintegration.
“This is very much a placard of the times,” declares Chugh, noting that at least 25 states play a joke on laws or ordinances mandating that, if dissection is part of a school’s curriculum, students be required to have an alternative to dissection. “It’s a mainstream authenticity.”
Additionally, the exigency execrate of V-Frog means students are not constrained to a lab milieu. The phase-of-the-art outcome complies with both inquiry and life science standards. Instructors can also pattern a dissection, observable by the continuous class, using a projector. This teaching and learning go through can be conveniently repeated as many times as desired.
V-Frog passed an important milestone when California approved V-Frog for permitted and social compliance as per their Formal enter of Tutelage guidelines. It is also in the definitive stages of a similar assessment in New York State. According to Chugh, V-Frog’s simulated dissection is more economical than real dissection scheduled to its ditty-space empower cost versus annual replacement of veritable frogs, dissection supplies and chemicals.
—————————-
Article adapted by Medical Dope Today from original press release.
—————————-
Tactus Technologies received a Small Business development grant from the Institute of Educational Services, a division of the U.S. Dept. of Education, for the development of V-Frog, which has a patent pending. Others involved in into and development of V-Frog — which drew upon some 120 sources in its inclusive production — include Kesh Kesavadas, Ph.D., chief technology narc in spite of Tactus Technologies; James Mayrose, Ph.D., chief executive officer, and James Lalley, Ph.D., director of educational products. Kesavadas is director of UB’s Essential Reality Lab and an associate professor of mechanical and aerospace engineering.
Additional information is at at http://www.vfrog.net/.
The University at Buffalo is a primary research-intensive blatant university, a flagship installation in the State University of Trendy York system that is its largest and most exhaustive campus. UB’s more than 28,000 students pursue their collegiate interests by way of more than 300 undergraduate, graduate and professional estate programs.
Founded in 1846, the University at Buffalo is a member of the Pairing of American Universities.
Informant: John DellaContrada
University at Buffalo
Babies from frozen embryos less likely to be premature
Publciado por deprivedputs - 02/03/10 a las 09:03:28 amA Danish lessons has found that IVF babies born from embryos that are frozen are less favourite to be underweight or unseasonable than those conceived during fresh treatment cycles.
Frozen embryos are thawed before they are used and there has been some concern in the past that the freezing process possibly damages the embryo in some way.
The researchers found that the average birth weight of those babies was 200g more than in fresh-embryo IVF and they say the use of frozen embryos could soon be accepted as a completely safe procedure which can be used even more frequently.
The team led by Anja Pinborg, of the Copenhagen University Hospital, say the findings are important because women are increasingly encouraged to use one fresh embryo in order to avoid multiple births and to freeze any others produced in the process for use later.
Dr. Pinborg says it is highly unlikely that freezing improved the health of embryos and a possible explanation might be that the patients who froze embryos were generally young women with a good prognosis and also that poor quality embryos were more likely to die during the thawing process.
Dr. Pinborg presented the research at the European Society of Human Reproduction and Embryology conference in Barcelona this week and says the findings are reassuring.
Another team of researchers from Yale University also at the conference say that IVF success rates could be improved by as much as 15 per cent with a “viability index” for selecting embryos with the best chance of a healthy pregnancy.
The new “fitness test” can apparently predict which IVF embryos will implant into the womb up to 70 per cent of the time and is a non-invasive procedure done from cultures grown in the laboratory.
The team say the technology, known as metabolomics, should be ready for widespread use within two to three years and could become a routine part of fertility treatment.
Bustiers To Benefit Breast Cancer
Publciado por deprivedputs - 28/02/10 a las 12:02:35 amCrittenton Hospital Medical
Center is hosting a unique event, Bustiers to Benefit Breast Cancer, which
will raise funds to wrestle with titty cancer and provide scholarships to redone
emerging approach designers.
Crittenton’s North Lobby hand down be transformed into an exhibit gallery
for the things turned out, which will perform 12 original bustiers created by students
from the International Academy of Originate and Technology, in Troy.
Second-year students from the Academy were invited to create haute couture
bustiers and compete someone is concerned erudition prizes — with one simple instruction
– the bustier must use pink fabric barely, and line the fashions with the
recognizable pink breast cancer ribbon logo fabric. The students with the
most outstanding designs compel be awarded scholarship funds. The panel of
judges are recognized local members of the fashion manufacture. Some of the
bustiers will be modeled during the in any case by their young innovative
designers.
This unique fundraiser intent be held on Thursday, October 12, from 5 to
7 p.m. at Crittenton Hospital’s North Lobby. The one-of-a-kind bustiers
will go dwelling with the lucky bidders in a silent auction which intention be held
that evening. The concerted event bequeath feature music, cocktails, kind-hearted hors
d’oeuvres and a unveiling from a knocker cancer survivor.
Tickets in requital for this exciting event are readily obtainable at three levels: Friend
for $50, Patron seeking $100 and Backer instead of $150 and can be purchased
through the Crittenton Hospital Medical Center Foundation. The Groundwork
may be reached by vocation (248) 652-5345.
Crittenton Hospital Medical Center
http://www.crittenton.com
Navajo Nation Council Votes To Ban Public Smoking On Reservation
Publciado por deprivedputs - 26/02/10 a las 03:02:50 amThe Navajo Polity Caucus on Friday voted 42-27 to embargo smoking and chewing tobacco in public places on the reservation, the AP/Arizona Constantly Star reports. The ban does not include tobacco used in ceremonies on the territory, located on portions of Arizona, Green Mexico and Utah.
The tribe’s Line of Strength would oversee compliance with the ban and issue fines of $100 benefit of the elementary violation, $200 due to the fact that the second and $500 pro the third. Increasing hours of community putting into play also would be an option for violators of the embargo.
Navajo Nation President Joe Shirley has 10 days to sign or turn-down the legislation. Thomas Walker, sponsor of the tobacco embargo legislation, said that Shirley has not made a escort commitment to sign it, though two years ago Shirley made a tobacco-free broadcasting of his own.
Walker added, “I think the council made a wise decision that puts the health and well-being of the people first.” Patricia Nez Henderson, vice president of the Blackhill Center appropriate for American Indian Robustness, said that the ban could help discourage prepubescent tribal members from starting to smoke as well as help others who want to stop smoking and protect nonsmokers from secondhand smoke.
The Navajo Nation Gaming Enterprise opposes the tobacco ban, saying that it could set off a don the tribe’s first casino at a injury because competitors until now would permit smoking. The casino is expected to open later this year (Major Holmes, AP/Arizona Always Star, 7/28).
NPR’s “Morning Edition” on Monday reported on the proscribe (Herz, “Morning Edition,” NPR, 7/28).
Reprinted with style permission from http://www.kaisernetwork.org. You can view the unscathed Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Probe is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Establishment.
© 2008 Advisory Board Company and Kaiser Ancestors Foundation. All rights reserved.
Avail the finest tooth whitening resolutions
Publciado por deprivedputs - 23/02/10 a las 12:02:43 pmAs good as, every belittling on the eyeball to eyeball in defiance of of world, dreams to have astounding white teeth. In order to keep our teeth shimmery and thoroughly, we make our choicest efforts. No one would contract pleasure from to have the stained teeth that are caused normally owing to the assorted rule along with the eatables like the tea, coffee, tobacco, etc. Persons with in these cravings without realizing about their baleful effects on our charming teeth along with that being the case finally our grin. They thus unhurriedly evade having munificent chats with others along with responding people with a grin. In cities like Sydney, persons believe much give their facade, qualities in into the bargain to appearance. It gets much baroque for folks with stained teeth to opening night c end up with other persons around them. In the future, it was contemplation to be unworkable to regain the pallor of your teeth. You are right away able to entirely survive your gone optimistic grin with the help of the latest innovations in the cosmetic dentistry subjection. Looking at the growing stipulation of individuals, diversified current teeth whitening keys hold been formulated, in formulated times. The teeth whitening treatments get going a kick for all to see of the Zoom teeth whitening that is also called as the laser teeth whitening way as well as the assorted unique bleaching systems along with the abode based cures. Individuals who hold missing their smile can justifiable now effortlessly salvage it with the boost of the zoom whitening original. o The zoom whitening set-up has revolutionized the entire department of cosmetic dentistry as it removes the discolorations from your teeth as immeasurably as makes them look more unsurpassed. The zoom whitening in Sydney is exceptionally well known as fountain as peradventure the most pursued method. The treatment is chosen for its straightforwardness, effortlessness as well as most importantly crave permanent results. The follow of the treatment continues extended than any other method. The broad durability of the zoom whitening raise is nearly five to six years. A defensive layer is created by the zoom whitening set-up, which prevents your teeth from further damage. However, the make is awfully venerated along with therefore not many folks hunting it. o The other teeth whitening strips and the composed based bleaching packages are also made ready seeing the growing qualification of individuals. Being budget-priced, these manners desist from exceptionally in a word constantly results. But, due to their being fetch-crap along with instantaneous in giving result, individuals trail them more normally than the other expensive systems. So, take exquisite follow of your teeth and seduce sure that you treat the unsurpassed treatment in spite of them.
Successful human trial of obesity drug that mimicks metabolic effects of growth hormone
Publciado por deprivedputs - 19/02/10 a las 04:02:51 pmMetabolic Pharmaceuticals Limited today announced the happy result of its Inject 2b human trial of AOD9604 for weight.
The AOD9604 molecule is a small orally active peptide modelled on one section of the human growth hormone molecule. Growth hormone naturally occurs in the body and has profound stimulatory effects on fat metabolism, with levels of the hormone typically becoming suppressed in the obese state. Daily dosing with AOD9604 restores suppressed fat metabolism in the obese by mimicking the fat metabolic effects of growth hormone.
The 300 trial subjects were comprised of men and women aged 30 to 65 years with a body mass index (or BMI, being weight in kg divided by the square of height in meters) of 35 or higher. Trial subjects received daily doses of AOD9604 or placebo in 0mg (placebo), 1mg, 5mg, 10mg, 20mg, or 30mg quantities. There were 50 subjects in each dose group. The average age of the trial participants was 44 years and their average weight was 122 kilograms (268 lbs). The trial was randomized, double blind and placebo-controlled.
The primary efficacy endpoints of the study were to determine the effect of AOD9604 on body weight reduction and/or fat reduction. The group receiving the 1mg dose lost the most weight, averaging a weight loss over the 12 weeks of 2.8 kilograms (6.2 lbs), more than triple the weight lost by those on placebo, who lost an average of 0.8 kilograms (1.8 lbs). The rate of weight loss was maintained throughout the treatment period, which is an encouraging trend for expectations of longer-term dosing.
AOD9604 also demonstrated compared to placebo a small but consistent improvement in cholesterol profiles, and a reduction in the number of patients with impaired glucose tolerance.
At all doses the drug demonstrated excellent tolerability, with no evidence for the side effects commonly experienced with existing drugs.
Prof. Louis J Aronne MD, President of the North American Association for the Study of Obesity and a member of Metabolic’s Clinical Advisory Panel, said, “This is an exciting new approach to a problem which has defied easy solutions. We will need many different treatments if we are going to manage obesity successfully, in much the same way we have many treatments available for diabetes and hypertension. Unlike currently available treatments which rely on reducing calorie intake, this one appears to work primarily on metabolic pathways and merits further investigation.”
“We are delighted with these results,” stated Metabolic Pharmaceuticals CEO, Dr. Chris Belyea. “The evidence from the trial is that AOD9604 induces competitive weight loss at a low dose with accompanying health benefits and has superior tolerability. Our next focus is to secure a partnership with a major pharmaceutical company to assist in financing late stage longer term human clinical trials for worldwide marketing approval as a prescription treatment.”
Prof. Michael Jensen MD, an expert on lipid metabolism, a past president of the North American Association for the Study of Obesity, and a member of Metabolic’s US Clinical Advisory Panel, stated, “The scientific idea behind AOD9604 is an elegant one and completely different from the existing approaches to obesity. The interesting trial results reported here by Metabolic clearly justify further development and I look forward to seeing the future outcome.”
Obesity is the Western World’s most common health problem. Published research has indicated that more than 20% of the adult population in developed countries is obese, which is more than 300 million adults worldwide. In addition, more than 50% of adults in developed countries are overweight.
http://www.metabolic.com.au/
Lancet, Lancet Infectious Diseases Publish HIV/AIDS-Related Articles
Publciado por deprivedputs - 18/02/10 a las 08:02:51 amThe most up to date issues of the journals Lancet and Lancet Infectious Diseases included articles kin to HIV/AIDS issues. Headlines appear cheaper than.
Lancet
- “Confessions of a Condom Lover” (Shelton, Lancet, 12/2).
- “Does the World Need Another AIDS Authority?” (Billingham, Lancet, 12/2).
- “Does the World Need Another AIDS Authority?” (De Cock/Mane, Lancet, 12/2).
- “Does the World Need Another AIDS Authority?” (Obasi/Tovey, Lancet, 12/2).
- “Global Control of Sexually Transmitted Infections” (Low et al., Lancet, 12/2).
- “Microfinance, Intimate Partner Violence and HIV” (Lancet, 12/2).
- “Promoting Protection and Pleasure: Amplifying the Effectiveness of Barriers Against Sexually Transmitted Infections and Pregnancy” (Philpott et al., Lancet, 12/2).
Lancet Catching Diseases
- “Chinese Officials Ban HIV Education Institute” (Cheng, Lancet Infectious Diseases, December 2006).
- “Global Fund Fails To Appoint New Executive Director” (Das, Lancet Infectious Diseases, December 2006).
- “HIV Infection as a Weapon of War” (Millis/Nachega, Lancet Infectious Diseases, December 2006).
- “HIV-1 Infection of Mononuclear Phagocytic Cells: The Case for Bacterial Innate Immune Deficiency in AIDS” (Noursadeghi et al., Lancet Infectious Diseases, December 2006).
- “Study Reveals Extent of Rape in Spread of HIV/AIDS” (Baleta, Lancet Infectious Diseases, December 2006).
- “WHO and UNAIDS Set Controversial Course for HIV Testing” (Bass, Lancet Infectious Diseases, December 2006).
“Reprinted with consent from http://www.kaisernetwork.org. You can view the entire Kaiser Diurnal Health Behaviour Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Behaviour Report is published due to the fact that kaisernetwork.org, a honest utility of The Henry J. Kaiser Family Rationale . © 2005 Advisory Board Proprietorship and Kaiser Family Foundation. All rights reserved.